George Magrath is Chief Executive Officer of Ocuphire Pharma, Inc.. Currently has a direct ownership of 392,950 shares of OCUP, which is worth approximately $455,821. The most recent transaction as insider was on Nov 01, 2024, when has been sold 37,050 shares (Common Stock) at a price of $1.18 per share, resulting in proceeds of $43,719. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 393K
8.62% 3M change
1.76% 12M change
Total Value Held $455,821

George Magrath Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2024
SELL
Payment of exercise price or tax liability
$43,719 $1.18 p/Share
37,050 Reduced 8.62%
392,950 Common Stock
May 17 2024
BUY
Open market or private purchase
$8,750 $1.75 p/Share
5,000 Added 1.15%
430,000 Common Stock
Mar 18 2024
BUY
Open market or private purchase
$49,000 $1.96 p/Share
25,000 Added 5.56%
425,000 Common Stock
Nov 01 2023
BUY
Grant, award, or other acquisition
-
400,000 Added 50.0%
400,000 Common Stock
GM

George Magrath

Chief Executive Officer
Farmington Hills, MI

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP